HMM304 - Therapeutic Development

Year: 2018 unit information
Enrolment modes: Trimester 2: Burwood (Melbourne), Waurn Ponds (Geelong)
Credit point(s): 1
EFTSL value: 0.125
Unit chair:

Craig Smith

Prerequisite:

HMM202 or SLE212

Corequisite:

Nil

Incompatible with:

Nil

Contact hours:

1 x 2 hour class per week and 1 x 1 hour (equivalent) online class per week and 1 x 1 hour seminar per week

Content

This unit describes how therapeutics such as pharmacological drugs are discovered and developed, in order to treat disease. Non-targeted and targeted drug discovery is discussed, in addition to target validation, in the contexts of big pharmaceutical companies and smaller research laboratories. Drug development strategies and pipelines that are adopted by big pharmaceutical companies are then described, including the chemical optimisation of lead compounds, pre-clinical and clinical trials, commercialisation and post-market considerations.

Assessment

Assessment task 1: Seminar and workshop assessments (weekly assessments) 15%

Assessment task 2: Mid-trimester test (45 minutes) 20%

Assessment task 3: Written report (1500 words) 20%

Assessment task 4: Examination (2 hours) 45%

Prescribed texts

Raymond G. Hill & Humphrey P. Rang. Drug Discovery and development second edition 2013.

Unit Fee Information

Click on the fee link below which describes you: